Q3 2022 · 13F-HR/A
AJU IB Investment Co., Ltd.holdings as filed
Filed 2022-11-14 · accession 0001140361-22-041156
$58,416
Reported value
7
Positions
2022-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $25,919 | 44.4% | 1,380,890 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $10,920 | 18.7% | 754,678 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $9,950 | 17.0% | 457,059 | Common | SOLE |
| 81578P106 | SEER | SEER INC | $6,319 | 10.8% | 816,375 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $2,394 | 4.10% | 99,503 | Common | SOLE |
| 98422T100 | — | XILIO THERAPEUTICS INC | $1,943 | 3.33% | 667,742 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $971 | 1.66% | 175,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.